Christopher J. Kemp

14.0k total citations · 3 hit papers
166 papers, 9.7k citations indexed

About

Christopher J. Kemp is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Christopher J. Kemp has authored 166 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 69 papers in Oncology and 27 papers in Cancer Research. Recurrent topics in Christopher J. Kemp's work include Cancer-related Molecular Pathways (46 papers), Parkinson's Disease Mechanisms and Treatments (22 papers) and Cancer Research and Treatments (19 papers). Christopher J. Kemp is often cited by papers focused on Cancer-related Molecular Pathways (46 papers), Parkinson's Disease Mechanisms and Treatments (22 papers) and Cancer Research and Treatments (19 papers). Christopher J. Kemp collaborates with scholars based in United States, United Kingdom and South Africa. Christopher J. Kemp's co-authors include Kay E. Gurley, Allan Balmain, Steven Henikoff, Fan Yang, Shannon R. Payne, Sheila S. Teves, Karen S. Kelly‐Spratt, Matthew L. Fero, James M. Roberts and Allan Bradley and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Christopher J. Kemp

161 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

1998 655 citations Kay E. Gurley, Christopher J. Kemp et al. profile →
Doxorubicin, DNA torsion, and chromatin dynamics

2013 537 citations Fan Yang, Christopher J. Kemp et al. profile →
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration

2015 285 citations Katrina L. Paumier, Kelvin C. Luk et al. profile →

Peers

Countries citing papers authored by Christopher J. Kemp

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Kemp more than expected).

Fields of papers citing papers by Christopher J. Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Kemp. The network helps show where Christopher J. Kemp may publish in the future.

Co-authorship network of co-authors of Christopher J. Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Kemp. A scholar is included among the top collaborators of Christopher J. Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Kemp. Christopher J. Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition 2024 ·Journal of Neuroinflammation ·(unknown), Christopher J. Kemp, Joseph R. Patterson, (unknown), Nathan C. Kuhn, Matthew J. Benskey, Megan F. Duffy, Kelvin C. Luk, Caryl E. Sortwell	5
2	Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing 2023 ·npj Precision Oncology ·Heidi J. Gray, Payel Chatterjee, Rachele Rosati, (unknown), (unknown), Robert L. Diaz, (unknown), (unknown), (unknown), (unknown), Katannya Kapeli, (unknown), (unknown), Kalyan Banda, Barbara A. Goff, Elizabeth M. Swisher, Brady Bernard, Christopher J. Kemp, Carla Grandori	20
3	Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL 2022 ·Cancer Research ·Russell Moser, James Annis, Olga Nikolova, (unknown), Kay E. Gurley, Eduardo Méndez, Kim Moran‐Jones, Craig Dorrell, Rosalie C. Sears, Calvin J. Kuo, Haiyong Han, Andrew V. Biankin, Carla Grandori, Daniel D. Von Hoff, Christopher J. Kemp	4
4	Synthetic lethal kinases in Ras/p53 mutant squamous cell carcinoma 2022 ·Oncogene ·Russell Moser, Kay E. Gurley, Olga Nikolova, Guangrong Qin, (unknown), Eduardo Méndez, Ilya Shmulevich, Amanda K. Ashley, Carla Grandori, Christopher J. Kemp	4
5	Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma 2021 ·Molecular Cancer Therapeutics ·Shogo Shigeta, Goldie Y.L. Lui, Reid Shaw, Russell Moser, Kay E. Gurley, (unknown), Rachele Rosati, Robert L. Diaz, Tan A. Ince, Elizabeth M. Swisher, Carla Grandori, Christopher J. Kemp	22
6	Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo 2019 ·Journal of Visualized Experiments ·Joseph R. Patterson, Nicole K. Polinski, Megan F. Duffy, Christopher J. Kemp, Kelvin C. Luk, Laura A. Volpicelli‐Daley, Nicholas M. Kanaan, Caryl E. Sortwell	35
7	Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer 2018 ·Clinical Cancer Research ·Chang Xu, Olga Nikolova, Ryan Basom, Ryan M. Mitchell, Reid Shaw, Russell Moser, (unknown), Kay E. Gurley, Michael Kao, (unknown), Franz X. Schaub, Robert L. Diaz, (unknown), In Sock Jang, Justin Guinney, Vijayakrishna K. Gadi, (unknown), Carla Grandori, Christopher J. Kemp, Eduardo Méndez	19
8	Subthalamic Nucleus Deep Brain Stimulation Employs trkB Signaling for Neuroprotection and Functional Restoration 2017 ·Journal of Neuroscience ·D. Luke Fischer, Christopher J. Kemp, Allyson Cole-Strauss, Nicole K. Polinski, Katrina L. Paumier, Jack W. Lipton, Kathy Steece‐Collier, Timothy J. Collier, (unknown), Caryl E. Sortwell	42
9	Anthracyclines induce double-strand DNA breaks at active gene promoters 2015 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Fan Yang, Christopher J. Kemp, Steven Henikoff	78
10	Functional Kinomics Identifies Candidate Therapeutic Targets in Head and Neck Cancer 2014 ·Clinical Cancer Research ·Russell Moser, Chang Xu, Michael Kao, James Annis, (unknown), (unknown), Kay E. Gurley, In Sock Jang, Asel Biktasova, Wendell G. Yarbrough, (unknown), Carla Grandori, Christopher J. Kemp, Eduardo Méndez	66
11	Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads 2014 ·BMC Cancer ·Alanna Ruddell, (unknown), Karen S. Kelly‐Spratt, Momoko Furuya, Christopher J. Kemp	16
12	Systematic Screen Identifies miRNAs That Target RAD51 and RAD51D to Enhance Chemosensitivity 2013 ·Molecular Cancer Research ·Jen‐Wei Huang, Yemin Wang, Kiranjit K. Dhillon, Philamer Calses, Emily Villegas, Patrick S. Mitchell, Muneesh Tewari, Christopher J. Kemp, Toshiyasu Taniguchi	81
13	MYC-Driven Tumorigenesis Is Inhibited by WRN Syndrome Gene Deficiency 2012 ·Molecular Cancer Research ·Russell Moser, Masafumi Toyoshima, Kristin Robinson, Kay E. Gurley, Heather L. Howie, Jerry Davison, Martin Morgan, Christopher J. Kemp, Carla Grandori	43
14	MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition 2012 ·Cancer Research ·Yemin Wang, Jen‐Wei Huang, Philamer Calses, Christopher J. Kemp, Toshiyasu Taniguchi	103
15	Subthalamic Nucleus Stimulation Increases Brain Derived Neurotrophic Factor in the Nigrostriatal System and Primary Motor Cortex 2011 ·Journal of Parkinson s Disease ·Anne L. Spieles-Engemann, Kathy Steece‐Collier, Michael M. Behbehani, Timothy J. Collier, Susan L. Wohlgenant, Christopher J. Kemp, Allyson Cole-Strauss, Nathan Levine, Sara E. Gombash, (unknown), Jack W. Lipton, Caryl E. Sortwell	76
16	cDNA microarray analysis of adapting bowel after intestinal resection 2001 ·Journal of Pediatric Surgery ·Lawrence E. Stern, Christopher R. Erwin, Richard A. Falcone, Frederick S. Huang, Christopher J. Kemp, Jodi L. Williams, Brad W. Warner	34
17	Epithelial Permeability Is Not Increased in Rats Following Small Bowel Resection 2001 ·Journal of Surgical Research ·David O’Brien, L. A. Nelson, Lawrence E. Stern, Jodi L. Williams, Christopher J. Kemp, (unknown), (unknown), Christopher R. Erwin, Per-Olof Hasselgren, Brad W. Warner	11
18	Bax is required for increased enterocyte apoptosis after massive small bowel resection 2000 ·Surgery ·Lawrence E. Stern, Frederick S. Huang, Christopher J. Kemp, Richard A. Falcone, Christopher R. Erwin, Brad W. Warner	49
19	Induction of different genetic changes by different classes of chemical carcinogens during progression of mouse skin tumors 1994 ·Molecular Carcinogenesis ·Rod Bremner, Christopher J. Kemp, Allan Balmain	26
20	A revised map position for the Ha‐ras gene on mouse chromosome 7: Implications for analysis of genetic alterations in rodent tumors 1993 ·Molecular Carcinogenesis ·Christopher J. Kemp, Rod Bremner, Allan Balmain	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact